证券简称：恒立退 证券代码：000622 公告编号：2025-58 恒立实业发展集团股份有限公司 成立日期：1988 年 7 月 28 日 关于聘请主办券商的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 恒立实业发展集团股份有限公司（以下简称"公司"）于 2025 年 6 月 17 日 收到深圳证券交易所（以下简称"深交所"）送达的《关于恒立实业发展集团股 份有限公司股票终止上市的决定》（深证上〔2025〕595 号），深交所决定终止 公司股票上市。 一、聘请主办券商的情况说明 根据深交所《股票上市规则》《关于退市公司进入退市板块挂牌转让的实施 办法》等有关规定，公司股票终止上市后，将转入全国股转公司代为管理的退市 板块（以下简称"退市板块"）进行股份转让。公司应聘请股份转让服务机构（以 下简称"主办券商"），委托该机构提供进入退市板块挂牌转让服务，并授权其 办理证券交易所市场登记结算系统的股份退出登记、股份重新确认、退市板块的 股份初始登记及公司股票进入退市板块挂牌转让等事宜，保证公司股票在摘牌之 日起四十五个交易日内可以转让。 近日，公司与山西证券 ...

恒立退7月1日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 国金证券股份有限公司上海互联网证券分公司 | 17.77 | 1.01 | | 买二 | 国泰海通证券股份有限公司成都北一环路证券营业部 | 16.00 | 0.00 | | 买三 | 东方财富证券股份有限公司昌都两江大道证券营业部 | 16.00 | 4.10 | | 买四 | 华泰证券股份有限公司上海武定路证券营业部 | 15.79 | 1.89 | | 买五 | 德邦证券股份有限公司常州太湖东路证券营业部 | 12.44 | 0.00 | | 卖一 | 中国中金财富证券有限公司广州科学大道证券营业部 | 0.00 | 64.02 | | 卖二 | 东方财富证券股份有限公司拉萨金融城南环路证券营业 部 | 7.80 | 48.67 | | | 中国银河证券股份有限公司天津水上公园北道证券营业 | | | | 卖三 | | 0.00 | 18.78 | | | 部 | | | | 卖四 | 东方财富证券股份有限 ...

New Stock Issuance - The new stock "同宇新材" (code: 301630) is listed at an issuance price of 84.00[1] - "信通电子" (code: 001388) has an issuance price of 16.42[1] Rights Issues and Announcements - "济川药业" (code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - "中程退" (code: 300208) has 13 trading days remaining until the last trading day[1] - "退市锦港" (code: 600190) also has 13 trading days remaining until the last trading day[1] - "恒立退" (code: 000622) has 10 trading days remaining until the last trading day[1] Abnormal Fluctuations - "浙江东日" (code: 600113) reported severe abnormal fluctuations[1] - "汇金股份" (code: 300368) is noted for abnormal fluctuations[3]

证券简称：恒立退 证券代码：000622 公告编号：2025-57 恒立实业发展集团股份有限公司 关于公司股票进入退市整理期交易的第二次风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 6、对于将在股票摘牌后至完成退市板块初始登记期间到期的司法冻结业务， 建议有权机关在股票摘牌前通过原协助执行渠道提前办理续冻手续。 2025 年 6 月 17 日，公司收到深圳证券交易所（以下简称"深交所"）送达 的《关于恒立实业发展集团股份有限公司股票终止上市的决定》（深证上〔2025〕 595 号），深交所决定终止公司股票上市。根据《深圳证券交易所股票上市规则》 （以下简称"股票上市规则"）的相关规定，公司股票于 2025 年 6 月 25 日起进 1、恒立实业发展集团股份有限公司（以下简称"公司"）股票进入退市整理 期的起始日为 2025 年 6 月 25 日，退市整理期为十五个交易日，预计最后交易日 期为 2025 年 7 月 15 日。 2、公司股票于退市整理期届满的次一交易日摘牌，公司股票终止上市。 3、公司股票将在退市整理期交易十五个交易日， ...

证券简称：*ST 恒立 证券代码：000622 公告编号：2025-56 恒立实业发展集团股份有限公司 关于公司股票进入退市整理期交易首日的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、恒立实业发展集团股份有限公司（以下简称"公司"）股票于 2025 年 6 月 25 日复牌并进入退市整理期，退市整理期为十五个交易日，预计最后交易日期 为 2025 年 7 月 15 日。 2、公司股票于退市整理期届满的次一交易日摘牌，公司股票终止上市。 3、公司股票将在退市整理期交易十五个交易日，截至本公告日已交易 0 个交 易日，剩余 15 个交易日，交易期满将被终止上市，敬请投资者审慎投资、注意风 险。 4、公司股票在退市整理期交易期间，公司将不筹划或实施重大资产重组事项。 5、请投资者、证券公司等市场主体在股票摘牌前及时了结股票质押式回购、 约定购回、融资融券、转融通、深股通等业务。 6、对于将在股票摘牌后至完成退市板块初始登记期间到期的司法冻结业务， 建议有权机关在股票摘牌前通过原协助执行渠道提前办理续冻手续。 进入退市整理期交易。现将公 ...

Core Viewpoint - The decision by the Shenzhen Stock Exchange to delist Hengli Industrial marks the end of a long struggle for the company, which has faced significant operational decline and financial losses over the years [1][4]. Group 1: Company Performance and Financials - Hengli Industrial's stock will enter a delisting period starting June 25, 2025, with the final trading day expected to be July 15, 2025 [1]. - The company has experienced a drastic decline in revenue, with figures dropping from 346 million yuan in 2021 to 111 million yuan in 2023, and only 70.06 million yuan in the first three quarters of 2024 [1]. - The company reported a net profit of negative 33 million to negative 43 million yuan for the year 2024, despite a revenue forecast of 300 million to 350 million yuan [3]. Group 2: Strategic Moves and Challenges - In an attempt to avert delisting, Hengli Industrial acquired 100% of a newly established lithium battery materials processing company for no more than 15 million yuan in August 2024 [2]. - The acquisition led to a significant revenue increase in the fourth quarter, but the company faced discrepancies with its auditing firm regarding revenue figures, which were reported as only 196 million yuan [3]. - The company’s chairman obstructed the board's review of the annual report, leading to a delay that contributed to the delisting process [4]. Group 3: Industry Context and Implications - The failure of Hengli Industrial's cross-industry venture into lithium battery materials reflects a broader trend of over a hundred companies exiting the lithium battery sector due to industry oversupply and cyclical fluctuations [4]. - The case illustrates the regulatory environment under the new registration system, which has zero tolerance for "shell restructuring" and "financial engineering" practices [4]. - The shift in the new energy industry from rapid growth to refined competition indicates that companies lacking core competitiveness will face significant challenges [4].

证券简称：*ST 恒立 证券代码：000622 公告编号：2025-55 恒立实业发展集团股份有限公司董事会 恒立实业发展集团股份有限公司（以下简称"公司"）董事会于 2025 年 6 月 20 日收到董事马伟进先生的纸质书面辞职报告，马伟进先生因个人原因申请辞 去公司第十届董事会董事职务，其辞职后仍在公司工作。基于马伟进先生辞去董 事职务，其董事会战略与投资委员会委员职务亦相应辞去。 根据《中华人民共和国公司法》等的有关规定，马伟进先生的辞职不会导致 公司董事会成员低于法定人数，其辞职报告自送达公司董事会之日起生效。 马伟进先生系公司第二大股东深圳市傲盛霞实业有限公司（以下简称"傲盛 霞"）的实际控制人，截止本公告披露日，其通过傲盛霞间接持有公司 17,695,500 股股份，占公司总股本的 4.16%。 马伟进先生为促进公司规范运作和健康发展发挥了积极作用，公司及董事会 对马伟进先生在任职期间为公司作出的贡献表示衷心感谢！ 特此公告 恒立实业发展集团股份有限公司 关于公司董事辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2025 年 6 月 ...

Core Viewpoint - *ST Hengli is facing delisting due to negative net profit and insufficient revenue, with its stock entering a delisting preparation period starting June 25, 2025 [1][2] Group 1: Company Announcements - *ST Hengli received a notice of administrative penalty and will enter a delisting preparation period due to a negative audited net profit for 2023 and revenue below 100 million yuan [1] - The company has been warned of delisting risk since May 6, 2024, and has failed to disclose a majority of its board's assurance of the 2024 annual report by the legal deadline [1] - The stock will be delisted after a 15-day preparation period, with the delisting effective on the next trading day after the period ends [1] Group 2: Financial Performance - The company has experienced a significant decline in revenue and profitability since 2018, with 2023 revenue reported at only 79.54 million yuan, leading to a delisting risk warning [2] - For the first three quarters of 2024, *ST Hengli's revenue was merely 70.06 million yuan, indicating ongoing financial struggles [2] - Following an asset acquisition, the company reported a surge in revenue exceeding 200 million yuan in Q4 2024, but projected a loss of 33 to 43 million yuan for the year [3] Group 3: Industry Context - The company has attempted to pivot into the lithium battery sector, partnering with Ganfeng Lithium for comprehensive cooperation in the new energy industry chain [2] - The lithium battery industry is experiencing increased competition and overcapacity, leading to many cross-industry entrants facing challenges and withdrawing from the market [3] - A significant number of cross-industry lithium battery ventures have failed since 2023, highlighting the importance of focusing on core business and niche markets for survival [3]

Core Viewpoint - The article discusses the challenges faced by *ST Hengli, including its impending delisting due to negative net profit and declining revenues, as well as the broader issues in the lithium battery industry where many companies are struggling to adapt and survive amidst increasing competition and market saturation [2][4][7]. Company Overview - *ST Hengli, listed on the Shenzhen Stock Exchange since 1996, primarily engages in automotive parts manufacturing and the processing of new energy battery materials [3]. - The company has faced multiple delisting threats throughout its history, being labeled as "ST" (special treatment) several times due to financial difficulties [3]. - In 2023, *ST Hengli reported a significant loss with revenues dropping to 79.54 million yuan, leading to a delisting risk warning [4]. Recent Developments - On June 18, 2024, *ST Hengli received a notice of administrative penalty and was informed of its stock entering a delisting preparation period due to failing to meet financial reporting requirements [2]. - The company attempted to mitigate its financial struggles by acquiring New Energy Co., Ltd. for 15 million yuan, aiming to enhance its revenue through this asset purchase [5]. Industry Context - The lithium battery industry is experiencing an adjustment period characterized by intensified competition and overcapacity, leading many cross-industry entrants to halt or terminate their investment projects [7]. - Since 2023, over 100 cross-industry lithium battery cases have been recorded, with many companies exiting the market, highlighting the difficulties of adapting to the industry's dynamics [8]. - The article emphasizes that companies should focus on their core business and adopt differentiated competition strategies to survive the cyclical adjustments in the industry [8].

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]